Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for GER Prevention in Preterm Infants
NCT02907632Phase 4Completed
- Start
- Apr 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Metoclopramide with Placebo (2 arms). Primary endpoint: Incidence of regurgitation episodes. Started Apr 2017; status: completed.
02
Drugs
metoclopramide
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02907632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907632.